Showing results (251-260 of 757) with videos related to

Sort By:
Pageof 76
Diabetologia|May 2, 2018
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®Bernard Zinman, Silvio E Inzucchi, Christoph Wanner, et al.
Virus Research|February 12, 2024
Transcriptomics of Marburg virus-infected primary proximal tubular cells reveals negative correlation of immune response and energy metabolismBenjamin Koch, Maximilian Filzmayer, Sammy Patyna, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2014
Nephropathy in illicit drug abusers: a postmortem analysisMaike Buettner, Stefan W Toennes, Stefan Buettner, et al.
Biochemical Pharmacology|August 9, 2003
IL-18BPa:Fc cooperates with immunosuppressive drugs in human whole bloodMarcel Nold, Ingeborg A Hauser, Sonja Höfler, et al.
International Journal of Molecular Sciences|September 29, 2017
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study)Nicholas Obermüller, Alexander R Rosenkranz, Hans-Walter Müller, et al.
Molecular Genetics and Metabolism|December 3, 2010
Expert opinion on temporary treatment recommendations for Fabry disease during the shortage of enzyme replacement therapy (ERT)Gabor E Linthorst, Dominique P Germain, Carla E M Hollak, et al.
Plos One|May 20, 2021
COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learningAnna Laura Herzog, Holger K von Jouanne-Diedrich, Christoph Wanner, et al.
Diabetes Care|August 28, 2012
Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetesAndrea Henze, Katharina M Espe, Christoph Wanner, et al.
European Heart Journal|March 23, 2013
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry diseaseJohannes Krämer, Markus Niemann, Dan Liu, et al.
European Journal of Preventive Cardiology|May 16, 2017
Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of CardiologyMartin Wagner, Christoph Wanner, Kornelia Kotseva, et al.
Pageof 76